European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 139, Issue 2 , Pages 127-132 , August 2008

Current guidelines on management of HIV-infected pregnant women: Impact on mode of delivery

  • Anna Suy

      Affiliations

    • Institut Clinic de Ginecologia, Obstetrícia i Neonatologia, Hospital Clínic, IDIBAPS, Barcelona, Spain
  • ,
  • Sandra Hernandez

      Affiliations

    • Institut Clinic de Ginecologia, Obstetrícia i Neonatologia, Hospital Clínic, IDIBAPS, Barcelona, Spain
  • ,
  • Claire Thorne

      Affiliations

    • Centre for Paediatric Epidemiology and Biostatistics, Institute of Child Health, University College London, London, UK
  • ,
  • Montserrat Lonca

      Affiliations

    • Servei de Malalties Infeccioses, Hospital Clínic, IDIBAPS, Barcelona, Spain
  • ,
  • Marta Lopez

      Affiliations

    • Institut Clinic de Ginecologia, Obstetrícia i Neonatologia, Hospital Clínic, IDIBAPS, Barcelona, Spain
  • ,
  • Oriol Coll

      Affiliations

    • Institut Clinic de Ginecologia, Obstetrícia i Neonatologia, Hospital Clínic, IDIBAPS, Barcelona, Spain
    • Corresponding Author InformationCorresponding author at: Servei de Medicina Materno-Fetal, C/Sabino de Arana 1, Hospital Clínic, 08029 Barcelona, Spain. Tel.: +34 93 227 56 00; fax: +34 93 227 56 05.

Received 4 March 2007 ,Revised 21 August 2007 ,Accepted 17 December 2007.

References 

  1. Dorenbaum A, Cunningham CK, Gelber RD, et al. Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission. A randomised trial. JAMA. 2002;288:189–198
  2. European Collaborative Study. Mother-to-child transmission of HIV Infection in the era of highly active antiretroviral therapy. Clin Infect Dis. 2005;40:458–465
  3. Navér L, Lindgren S, Belfrage E, et al. Children born to HIV-1-infected women in Sweden in 1982–2003: trends in epidemiology and vertical transmission. J Acquir Immune Defic Syndr. 2006;42:484–489
  4. The European Mode of Delivery Collaboration. Elective caesarean section versus vaginal delivery in preventing vertical HIV-1 transmission: a randomised clinical trial. Lancet. 1999;353:1035–1039
  5. The International Perinatal HIV Group. Mode of delivery and vertical transmission of HIV-1: a meta-analysis from fifteen prospective cohort studies. N Engl J Med. 1999;340:977–987
  6. European HIV in Obstetrics Group. Higher rates of post-partum complications in HIV infected than in uninfected women irrespective of mode of delivery. AIDS. 2004;18:933–938
  7. Iribarren JA, Ramos JT, Guerra L, et al. Recommendations of the Study Group for AIDS, Infectious Diseases, and Clinical Microbiology, the Spanish Paediatric Association, the National AIDS Plan and the Spanish Gynaecology and Obstetrics Society Prevention of vertical transmission and treatment of infection caused by the human immunodeficiency virus in the pregnant woman. Enferm Infecc Microbiol Clin. 2001;19:314–335
  8. The American College of Obstetricians and Gynecologists. ACOG Committee Opinion, Number 234. ACOG, Washington, DC; 2000.
  9. Suy A, Martinez E, Coll O, et al. Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy. AIDS. 2006;20:59–66
  10. Santamaria RVJ, Martín C, García G. Tablas españolas de pesos neonatales según edad gestacional. Barcelona, SA: Laboratorios Menarini; 1998;
  11. Connor EM, Sperling RS, Gelber RD, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Eng J Med. 1994;331:1173–1180
  12. National Institutes of Health Consensus development task force statement on caesarean childbirth. Am J Obstet Gynecol 1981; 139:902–9.
  13. Delfraissy J. HIV management in 2005. Presse Med. 2005;34(Suppl.):S5–S6
  14. British HIV Association, Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission. 2005. www bhiva org.
  15. European Collaborative Study the Swiss Mother + Child HIV Cohort Study. Combination antiretroviral therapy and duration of pregnancy. AIDS. 2000;14:2913–2920
  16. European Collaborative Study. Increased risk of adverse pregnancy outcomes in HAART-treated HIV-infected women in Europe. AIDS. 2004;17:2337–2339
  17. Garcia PM, Kalish LM, Pitt J, et al. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. N Eng J Med. 1999;341:394–402
  18. Shaffer N, Chuachoowong R, Mock PA, et al. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Lancet. 1999;353:773–780
  19. Thomas J, Paranjothy S. Royal College of Obstetricians and Gynaecologists Clinical Effectiveness Support Unit. National Sentinel Caesarean Section Audit Report. London: RCOG Press; 2001;
  20. Coll O, Fiore S, Floridia M, et al. Pregnancy and HIV infection: a European consensus on management. AIDS. 2002;16:S1–S18
  21. Mandelbrot L, Mayaux MJ, Bongain A, et al. Obstetric factors and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohorts. Am J Obstet Gynecol. 1996;175:661–667
  22. The International Perinatal HIV Group. Duration of ruptured membranes and vertical transmission of HIV-1: a meta-analysis from fifteen prospective cohort studies. AIDS. 2001;15:357–368
  23. Bulterys M, Chao A, Dushimimana A, Saah AJ. Fatal complications after cesarean section in HIV-infected women. AIDS. 1996;10:923–924
  24. Semprini AE, Castagna C, Ravizza M, et al. The incidence of complications after caesarean section in 156 HIV positive women. AIDS. 1995;9:913–917
  25. Read JS, Tuomala R, Kpamegan E, et al. Mode of delivery and postpartum morbidity among HIV-infected women: the women and infants transmission study. J. Acquir Immune Defic Syndr. 2001;26:236–245
  26. Marcollet A, Goffinet F, Firtion G, et al. Differences in postpartum morbidity in women who are infected with the human immunodeficiency virus after elective cesarean delivery, emergency cesarean delivery, or vaginal delivery. Am J Obstet Gynecol. 2002;186:784–789
  27. Read JS, Newell ML. Cesarean delivery for prevention of mother-to-child transmission of HIV. Cochrane Database Syst Rev. 2005;4
  28. Stutchfield P. Antenatal betamethasone and incidence of neonatal respiratory distress after elective caesarean section: pragmatic randomized trial. BMJ. 2005;331:662
  29. Taylor LK, Roberts CL, Olive EC, Henderson-Smart DJ. Risk of complications in a second pregnancy following caesarean section in the first pregnancy: a population-based study. Med J Aust. 2005;183:515–519

PII: S0301-2115(07)00520-9

doi: 10.1016/j.ejogrb.2007.12.007

European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 139, Issue 2 , Pages 127-132 , August 2008